(Newser) -
Scores of prescription drugs are getting cheaper, as name-brand patents expire and open the door to generic imitators. That's bad news for pharmaceutical companies, the
Times reports, but it means that an aging population ever more reliant on drugs will be paying as much as 80 percent less for them.
More »